These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9794705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
    Douma CE, de Waart DR, Zemel D, Struijk DG, Krediet RT.
    Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
    [Abstract] [Full Text] [Related]

  • 5. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT.
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [Abstract] [Full Text] [Related]

  • 6. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, Krediet RT.
    Adv Perit Dial; 1995 Dec; 11():36-40. PubMed ID: 8534733
    [Abstract] [Full Text] [Related]

  • 7. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT.
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Apr; 15(2):134-41. PubMed ID: 7612733
    [Abstract] [Full Text] [Related]

  • 10. Effect of indomethacin on peritoneal protein loss in a rabbit model of peritonitis.
    Peng H, Cheung AK, Reimer LG, Kamerath CD, Leypoldt JK.
    Kidney Int; 2001 Jan; 59(1):44-51. PubMed ID: 11135056
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.
    Steinhauer HB, Schollmeyer P.
    Kidney Int; 1986 Feb; 29(2):584-90. PubMed ID: 3457982
    [Abstract] [Full Text] [Related]

  • 12. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD.
    Smit W, van den Berg N, Schouten N, Aikens E, Struijk DG, Krediet RT.
    Kidney Int; 2004 Jan; 65(1):298-303. PubMed ID: 14675063
    [Abstract] [Full Text] [Related]

  • 13. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
    Douma CE, Zweers MM, de Waart DR, van der Wardt AB, Krediet RT, Struijk DG.
    Perit Dial Int; 1999 Jan; 19 Suppl 2():S358-64. PubMed ID: 10406547
    [Abstract] [Full Text] [Related]

  • 14. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L.
    Eur J Clin Invest; 1987 Feb; 17(1):43-52. PubMed ID: 3106050
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998 Feb; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 16. Changes in water transport across the peritoneum during treatment with continuous ambulatory peritoneal dialysis in selected patients with and without peritonitis.
    Radtke M, Albrektsen GE, Widerøe TE, Nilsen TI, Romundstad P, Hallan S, Aasarød K, Laegreid IK, Oien C.
    Perit Dial Int; 2004 Feb; 24(6):571-9. PubMed ID: 15559487
    [Abstract] [Full Text] [Related]

  • 17. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A, Fernando RL, Varghese Z.
    Blood Purif; 2004 Feb; 22(2):216-23. PubMed ID: 15044821
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Yang CW, Hwang TL, Wu CH, Lai PC, Huang JY, Yu CC, Shyr MH, Huang CC.
    Nephrol Dial Transplant; 1996 Dec; 11(12):2466-71. PubMed ID: 9017624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.